Laura Prendergast
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
7
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MURA Mural Oncology | Initiates: Strong Buy | $18 | $3.40 | +429.41% | 1 | Oct 4, 2024 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $3.23 | +395.36% | 2 | Aug 14, 2024 | |
| BDTX Black Diamond Therapeutics | Initiates: Outperform | $20 | $2.99 | +568.90% | 1 | Jul 31, 2024 | |
| THRD Third Harmonic Bio | Initiates: Outperform | $18 | $12.11 | +48.70% | 1 | Jun 7, 2024 | |
| RVMD Revolution Medicines | Upgrades: Strong Buy | $36 → $48 | $55.87 | -14.09% | 2 | Apr 10, 2024 |
Mural Oncology
Oct 4, 2024
Initiates: Strong Buy
Price Target: $18
Current: $3.40
Upside: +429.41%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $3.23
Upside: +395.36%
Black Diamond Therapeutics
Jul 31, 2024
Initiates: Outperform
Price Target: $20
Current: $2.99
Upside: +568.90%
Third Harmonic Bio
Jun 7, 2024
Initiates: Outperform
Price Target: $18
Current: $12.11
Upside: +48.70%
Revolution Medicines
Apr 10, 2024
Upgrades: Strong Buy
Price Target: $36 → $48
Current: $55.87
Upside: -14.09%